Vancouver Coastal Health Research Institute (VCHRI) supports tomorrow’s research leaders with the Top Graduating Doctoral Student Awards and the Rising Star Awards. These awards recognize outstanding contributions by VCHRI research trainees to research excellence, service as role models, and other contributions to the VCH research community.
Posted: 2018-05-29
Posted: 2018-05-17
The Vancouver Sun is running a five-part series on prostate cancer, written by Larry Pynn. Links will be added as stories are published.
Part 1: Shock and choices after the diagnosis
1 in 7 Canadian men get prostate cancer, and I am among them
Posted: 2018-05-09
Dr Peter Black has been awarded an MSFHR Health Professional-Investigator award in partnership with Vancouver Coastal Health Research Institute and VGH & UBC Hospital Foundation. The project, "Unraveling disparate roles of Notch-1 and Notch-2 signaling in bladder cancer" will further his ongoing work on the Notch signaling pathway in bladder cancer. Loss of the cell surface receptor Notch-1 drives growth of some bladder cancers, while increased Notch-2 activity drives other bladder cancers.
Posted: 2018-05-04
The Prostate Cancer Foundation (USA) published a news release on the development...
Posted: 2018-04-19
April 19, 2018 - The National Post article "Good economics and good health: How Canada’s pharmaceutical companies make an impact" describes how pharmaceutical companies partner with academic institutions to expedite therapeutic discoveries. In its interview with Brad Wheeler of the University of British Columbia's University-Industry Liaison Office, the Vancouver Prostat
Posted: 2018-03-08
Three recent publications led by our Centre’s PIs describe discoveries in the development of prostate cancer and progression to castration-resistant disease. This information provides new targets for the development of potential therapeutics.
Discovery of non-canonical activation of Hh signalling
Posted: 2018-02-20
VCHRI has published an article discussing Drs.Wyatt and Chi's recent findings published in Cancer Discovery. This work was the subject of an earlier news article at this site. Edited text of this article is below; visit VCHRI's site for the full text + images.
Posted: 2018-02-07
Dr. Lucia Nappi, a postdoctoral fellow working with Dr. Gleave at the VPC and clinical research fellow working with Drs. Kollmannsberger and Chi at the BCCA, has been awarded a 2018 Genitourinary Cancers Symposium Merit Award.
Posted: 2018-02-02
Yinan Li, a graduate student in Dr Xuesen Dong's lab, has won the Best...
Posted: 2018-01-26
Drs. Wyatt, Chi and their teams have a new Cancer Discovery publication, "Circulating tumor DNA genomics correlate with resistance to abiraterone and enzalutamide in prostate cancer," in which they identify novel genomic biomarkers that could ultimately help decide whether patients with advanced prostate cancer should receive abiraterone or enzalutamide.
